Suppr超能文献

腹会阴联合括约肌间切除术与腹会阴联合切除术治疗低位直肠癌的临床结果比较。

Comparison of the clinical results of abdominoperanal intersphincteric resection and abdominoperineal resection for lower rectal cancer.

作者信息

Tsukamoto Shunsuke, Kanemitsu Yukihide, Shida Dai, Ochiai Hiroki, Mazaki Junichi

机构信息

Department of Colorectal Surgery, National Cancer Center Hospital, 5-1-1 Chuo-ku, Tokyo, 104-0045, Japan.

出版信息

Int J Colorectal Dis. 2017 May;32(5):683-689. doi: 10.1007/s00384-017-2755-2. Epub 2017 Jan 16.

Abstract

BACKGROUND

The aim of this study was to compare the oncologic results of abdominoperanal intersphincteric resection (ISR) and abdominoperineal resection (APR).

METHODS

Between 2003 and 2014, 277 consecutive patients with stage I-III low rectal cancer located within 5 cm from the anal verge underwent curative ISR and APR. A retrospective comparison of these two procedures was performed.

RESULTS

Overall, 128 patients underwent ISR and 149 underwent APR. The ISR group had earlier clinical stages and shorter distal margins (p < 0.01). The 5-year relapse-free survival rates in patients who underwent ISR/APR were 84.7/74.7% with T1-2 tumors and 51.3/67.6% with T3-4 tumors. In T3-4 tumors, the rate of local recurrence was higher in the ISR group (13.2%) than in the APR group (3.8%). The 5-year relapse-free survival rates in patients who underwent ISR/APR were 89.7/92.3% for stage I cases, 84.4/87.5% for stage II cases, and 39.8/51.8% for stage III cases. Patients with stage III tumors had high rates of distant recurrence in both groups (24.3 vs. 26.3%).

CONCLUSION

ISR is a feasible surgical procedure for T1-2 tumors. Patients with stage III tumors should be considered for adjuvant therapy to control distant recurrence regardless of the surgical procedure.

摘要

背景

本研究旨在比较腹会阴经括约肌间切除术(ISR)和腹会阴联合切除术(APR)的肿瘤学结果。

方法

2003年至2014年期间,277例距肛缘5厘米以内的I-III期低位直肠癌连续患者接受了根治性ISR和APR。对这两种手术进行了回顾性比较。

结果

总体而言,128例患者接受了ISR,149例接受了APR。ISR组临床分期更早,远端切缘更短(p < 0.01)。接受ISR/APR的患者中,T1-2肿瘤的5年无复发生存率为84.7/74.7%,T3-4肿瘤为51.3/67.6%。在T3-4肿瘤中,ISR组的局部复发率(13.2%)高于APR组(3.8%)。接受ISR/APR的患者中,I期病例的5年无复发生存率为89.7/92.3%,II期病例为84.4/87.5%,III期病例为39.8/51.8%。两组III期肿瘤患者的远处复发率均较高(24.3%对26.3%)。

结论

ISR是治疗T1-2肿瘤的可行手术方法。无论采用何种手术方式,III期肿瘤患者都应考虑接受辅助治疗以控制远处复发。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验